Biomarkers in inflammometry pediatric asthma : utility in daily clinical practice
Asthma is a common disease in both high and lower income countries that starts early and persists often for life. A correct and accurate diagnosis, treatment and follow-up during childhood are essential for a better understanding of adult asthma and avoiding over- or under-treatment. Th2 inflammation in children with asthma symptoms is usually assessed by measuring with serum total IgE, blood eosinophilia and FeNO levels that may help to predict asthma, particularly in those infants and young children in whom lung function tests are difficult to perform. FeNO measurement, compared to intra-individual levels, may be useful also for ascertaining treatment adherence. Nevertheless, an isolated measurement may be insufficient and only the combination of these markers improves the diagnosis, phenotyping and follow-up of an asthmatic child.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
European clinical respiratory journal - 4(2017), 1 vom: 14., Seite 1356160 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sánchez-García, Silvia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Asthma |
|---|
| Anmerkungen: |
Date Revised 30.09.2020 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1080/20018525.2017.1356160 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM274882035 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM274882035 | ||
| 003 | DE-627 | ||
| 005 | 20231225004436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/20018525.2017.1356160 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0916.xml |
| 035 | |a (DE-627)NLM274882035 | ||
| 035 | |a (NLM)28815006 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sánchez-García, Silvia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biomarkers in inflammometry pediatric asthma |b utility in daily clinical practice |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Asthma is a common disease in both high and lower income countries that starts early and persists often for life. A correct and accurate diagnosis, treatment and follow-up during childhood are essential for a better understanding of adult asthma and avoiding over- or under-treatment. Th2 inflammation in children with asthma symptoms is usually assessed by measuring with serum total IgE, blood eosinophilia and FeNO levels that may help to predict asthma, particularly in those infants and young children in whom lung function tests are difficult to perform. FeNO measurement, compared to intra-individual levels, may be useful also for ascertaining treatment adherence. Nevertheless, an isolated measurement may be insufficient and only the combination of these markers improves the diagnosis, phenotyping and follow-up of an asthmatic child | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Asthma | |
| 650 | 4 | |a IgE | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a children | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a eosinophilia | |
| 650 | 4 | |a nitric oxide | |
| 650 | 4 | |a periostin | |
| 650 | 4 | |a phenotype | |
| 650 | 4 | |a severe asthma | |
| 700 | 1 | |a Habernau Mena, Alicia |e verfasserin |4 aut | |
| 700 | 1 | |a Quirce, Santiago |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European clinical respiratory journal |d 2014 |g 4(2017), 1 vom: 14., Seite 1356160 |w (DE-627)NLM254528708 |x 2001-8525 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2017 |g number:1 |g day:14 |g pages:1356160 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/20018525.2017.1356160 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2017 |e 1 |b 14 |h 1356160 | ||